PPD Q2 Revenue Increases
PPD has posted a net income of $21m for the second quarter of 2010 or $0.18 per diluted share, compared to $58.1m or $0.49 per diluted share, for
Amgen has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for Repatha (evolocumab) supporting its broader use prior to a first heart attack or stroke.
Upp Technology’s software selected from the suite includes IRMS|EM Emergency Management, IRMS|WM Warehouse Management and IRMS|BI Business Intelligence to provide the BSPS with real-time visibility, enhanced accuracy and